|
Envelope surface glycoprotein gp120
|
env
|
CCR5 expression inhibits HIV-1 gp120-mediated early actin rearrangement in CD4/CXCR4 expressing 293T cells |
PubMed
|
|
env
|
SMS2 is involved in HIV-1 gp120-induced phosphorylation and activation of PYK2 and reorganization and polymerization of F-actin |
PubMed
|
|
env
|
HIV-1 gp120-CXCR4 signaling triggers cofilin activation and actin reorganization, which are important for a post entry process leading to viral nuclear localization |
PubMed
|
|
env
|
Gelsolin overexpression impairs HIV-1 gp120-induced cortical F-actin reorganization and capping and gp120-mediated CD4-CCR5 and CD4-CXCR4 redistribution in permissive lymphocytes |
PubMed
|
|
env
|
The N-terminal leucine-rich repeat fragment of Slit2 inhibits HIV-1 gp120-induced actin polymerization in T cells |
PubMed
|
|
env
|
Inducible T-cell kinase (ITK) affects viral entry and gp120-induced actin reorganization |
PubMed
|
|
env
|
NHERF1 is required for HIV-1 gp120-induced actin rearrangement |
PubMed
|
|
env
|
Syntenin-1 is recruited toward HIV-1 gp120/gp41-driven virus/cell and cell/cell contacts, associates with CD4, limits HIV-1-induced cell fusion and viral entry, and modulates gp120/gp41-triggered actin polymerization and PIP2 accumulation |
PubMed
|
|
env
|
Lck phosphorylates CD3zeta and the TCR-CD3 complex is recruited to a virological synapse (VS) when cells interact with gp120+ICAM-1 bilayers, leading to creation of an F-actin-depleted zone |
PubMed
|
|
Envelope surface glycoprotein gp160, precursor
|
env
|
Treatment of cells with actin-depolymerizing agents or tubulin polymerization inhibitors largely reduces the percentage of cells with capped HIV-1 Gag and Env, indicating an intact actin and tubulin cytoskeleton is required for efficient assembly of HIV-1 |
PubMed
|
|
Envelope transmembrane glycoprotein gp41
|
env
|
Syntenin-1 is recruited toward HIV-1 gp120/gp41-driven virus/cell and cell/cell contacts, associates with CD4, limits HIV-1-induced cell fusion and viral entry, and modulates gp120/gp41-triggered actin polymerization and PIP2 accumulation |
PubMed
|
|
env
|
The interaction of the long cytoplasmic tail of HIV-1 gp41 with the carboxy-terminal regulatory domain of p115-RhoGEF inhibits p115-mediated actin stress fiber formation and activation of serum response factor (SRF) |
PubMed
|
|
Nef
|
nef
|
HIV-1 NA7 and SF2 Nef utilize their C-terminal aspartic acids to relocalize ACTA1 and ACTB (F-actin) |
PubMed
|
|
nef
|
HIV-1 Nef stabilizes podosomes and enhances the size of the F-actin core in human monocyte-derived macrophages |
PubMed
|
|
nef
|
HIV-1 Nef inhibits CXCL12 induced chemotaxis in Jurkat cells, monocytes, and PBMCs, which leads to marked downregulation of F-actin accumulation in cells |
PubMed
|
|
nef
|
HIV-1 Nef co-localizes with F-actin and reorganizes F-actin assembly in the cortical regions of human podocyte |
PubMed
|
|
nef
|
HIV-1 Nef induces loss of F-actin assembly and inhibits retinoid receptor-mediated transcription |
PubMed
|
|
nef
|
The HIV-1 Nef highly conserved valine-glycine-phenylalanine amino acid triplet (VGF) motif is essential for effects of Nef on actin dynamics and Lck localization |
PubMed
|
|
nef
|
HIV-1 Nef requires a PAK2 recruitment motif (F195/191I) for inhibition of actin remodeling and induction of cofilin hyperphosphorylation |
PubMed
|
|
nef
|
HIV-1 Nef disrupts F-actin at the cortical actin ring in both insulin-unstimulated and stimulated adipocytes |
PubMed
|
|
Pr55(Gag)
|
gag
|
No major differences in relative actin incorporation between wild-type HIV-1 and Gag virus-like particles (VLPs) and between Gag and Gag(LZ) VLPs, indicating that the NC domain of Gag is not required for actin incorporation into HIV-1 |
PubMed
|
|
gag
|
HIV-1 Gag assembly proceeds with normal rates when actin filaments are either disrupted or stabilized in cells, indicating that the actin network is dispensable for HIV-1 assembly |
PubMed
|
|
gag
|
HIV-1 Gag assembly and budding occur through an actin-driven mechanism |
PubMed
|
|
gag
|
Tec kinase chemical inhibitors diminish the recruitment of ITK to the plasma membrane perturbing HIV-1 Gag-ITK co-localization, disrupting F-actin polymerization, and inhibiting HIV-1 release and replication |
PubMed
|
|
gag
|
HIV-1 Gag, ITK, and F-actin are located in overlapping and discrete regions of T cell-T cell contact sites |
PubMed
|
|
gag
|
Treatment of cells with actin-depolymerizing agents or tubulin polymerization inhibitors largely reduces the percentage of cells with capped HIV-1 Gag and Env, indicating an intact actin and tubulin cytoskeleton is required for efficient assembly of HIV-1 |
PubMed
|
|
Tat
|
tat
|
Treatment with cannabinoids inhibits HIV-1 Tat-enhanced attachment of U937 cells to collagen IV, laminin, or ECM1 proteins, which is linked to the cannabinoid receptor type 2 and the modulation of beta1-integrin and actin distribution |
PubMed
|
|
tat
|
Treatment of primary hippocampal neurons with HIV-1 Tat produces a significant early reduction in F-actin labeled puncta. The cysteine rich domain (residues 22-37) of Tat is required for Tat-mediated reduction of F-actin labeled puncta |
PubMed
|
|
tat
|
Uptake of the HIV-1 Tat protein is regulated by arrangement of the actin cytoskeleton in epithelial cells |
PubMed
|
|
tat
|
Endothelial cell adherent to HIV-1 Tat induces rearrangement of actin cytoskeleton and is dependent on integrin alpha5beta3 |
PubMed
|
|
tat
|
In Jurkat cells expressing HIV-1 Tat, decreased expression levels are found for basic cytoskeletal proteins such as actin, beta-tubulin, annexin, cofilin, gelsolin, and Rac/Rho-GDI complex |
PubMed
|
|
tat
|
Most of the components of the SWI2/SNF2 chromatin remodeling complex (BRG1/BRM, BAF250, BAF180, BAF170, BAF155, BAF60a, BAF53A, actin and InI) except BRM, BAF155 and BAF57, are identified to interact with HIV-1 Tat in Jurkat cell |
PubMed
|
|
tat
|
Signaling from multivalent TatP facilitates the frequent and constitutive recruitment of TatR to actin-associated membrane lipid-rafts |
PubMed
|
|
tat
|
HIV-1 Tat induces actin cytoskeletal rearrangements through p21-activated kinase 1 (PAK1) and downstream activation of the endothelial NADPH oxidase, an effect that is lost by introduction of mutations into the Tat cysteine-rich or basic domains |
PubMed
|
|
matrix
|
gag
|
HIV-1 MA co-localizes with beta2 integrin, alphaM and alphaX integrins in the intracellular thick electron-dense membrane compartments, which contain talin, vinculin and paxillin that connect the integrin complexes to the actin cytoskeleton |
PubMed
|
|
gag
|
The localization of the HIV-1 reverse transcription complex to actin microfilaments is mediated by the interaction of a reverse transcription complex component (HIV-1 Matrix) with actin, but not vimentin (intermediate filaments) or tubulin (microtubules) |
PubMed
|
|
nucleocapsid
|
gag
|
HIV-1 NC-like aggregates are associated with dsDNA synthesis by HIV-1 RT and appear to efficiently bind to F-actin filaments, a property that may be involved in targeting complexes to the nuclear envelope |
PubMed
|
|
gag
|
Mature HIV-1 Nucleocapsid, as well as the nucleocapsid domain of the HIV-1 Gag polyprotein, binds filamentous actin resulting in incorporation of actin into virus particles and enhancement of cell motility |
PubMed
|
|
retropepsin
|
gag-pol
|
Actin, one of the most abundant proteins of the cell, is hydrolyzed by the human immunodeficiency virus type 1 (HIV-1) protease during acute infection of cultured human T lymphocytes |
PubMed
|
|
gag-pol
|
HIV-1 protease cleaves actin in vitro at amino acid residues 66-67, 94-95, and 126-127 |
PubMed
|
|
reverse transcriptase
|
gag-pol
|
HIV-1 NC-like aggregates are associated with dsDNA synthesis by HIV-1 RT and appear to efficiently bind to F-actin filaments, a property that may be involved in targeting complexes to the nuclear envelope |
PubMed
|
|
gag-pol
|
The localization of the HIV-1 reverse transcription complex to actin microfilaments is mediated by the interaction of a reverse transcription complex component (HIV-1 Matrix) with actin, but not vimentin (intermediate filaments) or tubulin (microtubules) |
PubMed
|